Switzerland-based pesticides maker Syngenta said on Wednesday that it has acquired a repository of natural compounds and ...

Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss ...

ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Emasan AG is offering around 26.5M shares in Swiss Novartis (NVS) through Goldman Sachs, potentially raising $3B, Pablo Mayo Cerqueiro of ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

Xealth, the leader in enabling digital health at scale, today announced that CEO and Co-founder Mike McSherry will join UPMC ...

The prevalence of type 2 diabetes is rising globally, with a disproportionate impact on individuals in low-income and middle-income countries, where access to care and new therapies is often limited.

Telangana life sciences sector gets a major boost at Bio Asia 2025: Our Bureau, Mumbai Wednesday, February 26, 2025, 11:30 Hrs [IST] The 22nd edition of BioAsia 2025, Asia’s lar ...

The first day of the BioAsia 2025 conference witnessed a major boost for Telangana in terms of the number of investments and ...

Panelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease ...